Organigram Expands Global Footprint With New Medical Cannabis Products in Australia
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Organigram Global ( (TSE:OGI) ) has issued an announcement.
Organigram Global is expanding its international medical cannabis portfolio by launching Edison and BOXHOT-branded vape and pastille products in Australia, adding 10 new SKUs to a market where it already supplies indoor-grown flower. The move taps rising Australian demand for consistent, ready-to-consume, non-flower formats and leverages Organigram’s Canadian expertise in high-quality, science-based formulations.
The Australian rollout, supported by a distribution partnership with Leafio, Montu Australia’s wholesale arm, is expected to give Organigram access to more than 4,000 pharmacies nationwide. Coupled with its proposed acquisition of Germany’s Sanity Group and visibility at the United in Compassion Medical Cannabis Symposium, the launch strengthens Organigram’s position as a global medical cannabis supplier and underscores its push into leading regulated markets beyond Canada.
The most recent analyst rating on (TSE:OGI) stock is a Buy with a C$3.50 price target. To see the full list of analyst forecasts on Organigram Global stock, see the TSE:OGI Stock Forecast page.
Spark’s Take on TSE:OGI Stock
According to Spark, TipRanks’ AI Analyst, TSE:OGI is a Neutral.
The score is held back primarily by weak operating profitability and negative cash flow despite revenue growth, reinforced by bearish technicals (below key moving averages and negative MACD). A low-leverage balance sheet and a moderate P/E provide partial support but are not enough to offset the core earnings and cash-flow risks.
To see Spark’s full report on TSE:OGI stock, click here.
More about Organigram Global
Organigram Global Inc. is a Canada-based licensed cultivator of cannabis and manufacturer of cannabis-derived products, listed on the NASDAQ Global Select Market and the Toronto Stock Exchange. The company is known for science-led development of non-flower formats such as vapes and pastilles, targeting regulated medical cannabis markets worldwide.
Average Trading Volume: 354,448
Technical Sentiment Signal: Sell
Current Market Cap: C$254.1M
Find detailed analytics on OGI stock on TipRanks’ Stock Analysis page.
